| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 6 |
| 1 | LENALIDOMIDE | 4 |
| 2 | CYCLOPHOSPHAMIDE | 3 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 3 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 3 |
| 5 | FLUDARABINE PHOSPHATE | 3 |
| 6 | FOLIC ACID | 3 |
| 7 | ACETAMINOPHEN | 2 |
| 8 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 2 |
| 9 | ACYCLOVIR | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | POTASSIUM ACETATE | 1 | 0.0007 |
| 1 | EMPAGLIFLOZIN AND LINAGLIPTIN | 1 | 0.0005 |
| 2 | ZINC SULFATE INJECTION, | 1 | 0.0003 |
| 3 | HYDROXYUREA | 2 | 0.0001 |
| 4 | FLUDARABINE PHOSPHATE | 3 | 0.0001 |
| 5 | IXAZOMIB | 2 | 0.0001 |
| 6 | FULVESTRANT | 2 | 0.0001 |
| 7 | BENRALIZUMAB | 1 | 0.0000 |
| 8 | PROGESTERONE | 1 | 0.0000 |
| 9 | IMATINIB MESYLATE | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 4 |
| 1 | Thalidomide Analog [EPC] | 4 |
| 2 | Vitamin C [EPC] | 4 |
| 3 | Alkylating Drug [EPC] | 3 |
| 4 | Vitamin B12 [EPC] | 3 |
| 5 | Vitamin D [EPC] | 3 |
| 6 | Antimetabolite [EPC] | 2 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 2 |
| 8 | Estrogen Receptor Antagonist [EPC] | 2 |
| 9 | Expectorant [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Estrogen Receptor Antagonist [EPC] | 2 | 0.0000 |
| 1 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 2 | Progesterone [EPC] | 1 | 0.0000 |
| 3 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 1 | 0.0000 |
| 5 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0000 |
| 7 | Arteriolar Vasodilator [EPC] | 1 | 0.0000 |
| 8 | Janus Kinase Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Alkylating Drug [EPC] | 3 | 0.0000 |